Matthew W. Martin

Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2

Namrata Bora-Singhal, Durairaj Mohankumar, Biswarup Saha et al. · Scientific Reports · 2020 · 90 citations · Full text

Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis

Daniel S. La, Julie Belzile, James Bready et al. · Journal of Medicinal Chemistry · 2008 · 73 citations · Full text

Pharmacotherapy, Pharmaceutical Chemistry, Novel 2,3-Dihydro-1,4-benzoxazines +20

Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation

Jean-Christophe Harmange, Matthew M. Weiss, Julie Germain et al. · Journal of Medicinal Chemistry · 2008 · 70 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Tumor Biology +17

Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck:  Synthesis, SAR, and in Vivo Anti-Inflammatory Activity

Erin F. DiMauro, John Newcomb, Joseph J. Nunes et al. · Journal of Medicinal Chemistry · 2006 · 67 citations · Full text

Pharmaceutical Science, Immunology, Immunologic Mechanism +20

Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11

Matthew W. Martin, Jennifer Y. Lee, David R. Lancia et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 64 citations · Full text

Medicinal Chemistry, Biochemistry, Novel N-hydroxy-2-arylisoindoline-4-carboxamides +9